Explore the full management transaction log of Metabolic Explorer, a publicly traded company based in France. Shares are listed on FR FR, under the authority of AMF. Operating in the Chemicals & Materials sector, Metabolic Explorer has recorded 10 public disclosures. The latest transaction was filed on 3 March 2023 — Souscription. Among the most active insiders: BPIFRANCE INVESTISSEMENT SAS. The full history is accessible without an account.
0 of 0 declarations
METabolic EXplorer (METEX) is a French industrial biotechnology group specialized in industrial fermentation and the production of natural-origin ingredients. Historically based in Clermont-Ferrand, the company was built around a scientific and industrial approach designed to replace petrochemical processes with fermentation-based processes using renewable feedstocks. It is listed on Euronext Paris under ISIN FR0004177046 and has long been viewed as a French small-cap industrial and biotech name. METEX’s business model focused on developing, scaling up and commercializing platform molecules and functional ingredients for three main end markets: animal nutrition, cosmetics and biopolymers. The group positioned itself as a provider of bio-based solutions for major industrial customers, with products and processes derived from fermentation rather than traditional chemical synthesis. Strategically, it aimed to combine specialty products with higher added value and commodity products, with the longer-term objective of reaching a more balanced revenue mix between those two segments. From an industrial standpoint, METEX built a meaningful production footprint through units such as METEX NØØVISTAGO and METEX NØØVISTA, which were intended to support scale-up and strengthen the company’s ambition of becoming a global reference in fermentation-derived functional ingredients. Its Clermont Limagne site, near Clermont-Ferrand, remained the historical core of the group’s activities, while additional industrial assets were integrated over time to expand capacity and flexibility. Geographically, the company was initially centered in France, but its commercial strategy targeted international markets, particularly across Europe and beyond, through industrial partnerships and customer relationships. METEX also emphasized local sourcing and a lower environmental footprint in its supply chain, highlighting in its 2022 sustainability report that more than 80% of purchases were sourced within 300 km and that 99.6% of plant outgoing flows were valorized. Recent corporate history is critical to understanding the company’s current profile. In June 2023, METEX published its 2022 sustainability report, underlining voluntary ESG commitments and decarbonization work. However, the company later faced severe financial distress: trading in the stock was suspended in March 2024, and in July 2024 the judicial reorganization proceedings affecting METEX NØØVISTAGO and METabolic EXplorer were converted into liquidation proceedings. These developments materially changed the company’s situation and are essential context for any investment or market analysis.